metaPreg - Lacosamide (All indications) during pregnancy

Lacosamide (All indications) updated on 06-15-2026

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.15 [0.83, 1.59]	0%	6 studies	161	146	not evaluable	ROB	-
Major congenital malformations	1.15 [0.83, 1.59]	0%	6 studies	161	146	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	0.51 [0.23, 1.13]	-	1 study	196	88	not evaluable	ROB	-
Small for gestational age (weight)	0.96 [0.45, 2.03]	-	1 study	132	88	not evaluable	ROB	-
Hide endpoints reported in only one study ...